You are here: All Products  > Innovent Signs $45 Million Deal to Commercialize Two Lilly Oncology Drugs in China

Innovent Signs $45 Million Deal to Commercialize Two Lilly Oncology Drugs in China

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.